CD8A and neoplasm: Furthermore, in vivo experiments revealed that the combination of 7rh and CIR exhibited remarkable increases in tumor-infiltrating CD8+ T lymphocytes (Fig. 7G) along with significant tumor growth suppression and regression trends (Fig. 7H, I).